Rachel E. Sobel
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Platelet Disorders and Treatments
- Iron Metabolism and Disorders
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Autoimmune and Inflammatory Disorders Research 3
- Co-authors
- Michael D. LockshinJane E. SalmonAlfred ZettnerC. A. FinchDoruk ErkanYusuf YazıcıLarry GorkinRichard L. Siegel
- Journals
- Pharmacoepidemiology and Drug Safety (4 papers)International Journal of Clinical Practice (3 papers)International Journal of Medical Informatics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Ophthalmology Retina (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Rachel E. Sobel
30 papers receiving 530 citations
Peers
Comparison fields: 5 of 88
- Rheumatology 215
- Hematology 126
- Toxicology 29
- Immunology 127
- Psychiatry and Mental health 63
Countries citing papers authored by Rachel E. Sobel
This map shows the geographic impact of Rachel E. Sobel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Sobel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Sobel more than expected).
Fields of papers citing papers by Rachel E. Sobel
This network shows the impact of papers produced by Rachel E. Sobel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Sobel. The network helps show where Rachel E. Sobel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel E. Sobel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 0 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 11 | |
| 12 | 2014 | 17 | |
| 13 | 2010 | 15 | |
| 14 | 2008 | 1 | |
| 15 | 2008 | 10 | |
| 16 | 2006 | 51 | |
| 17 | 2001 | 79 | |
| 18 | 1997 | 44 | |
| 19 | 1997 | 63 | |
| 20 | Amiodarone-induced dysthyroidism. | 1985 | 1 |
About Rachel E. Sobel
Rachel E. Sobel is a scholar working on Toxicology, Hematology, Dermatology, Immunology and Allergy and Pediatrics, Perinatology and Child Health, having authored 32 papers that have together received 541 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Systemic Lupus Erythematosus Research (4 papers), Sexual function and dysfunction studies (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Dermatology and Skin Diseases (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Rheumatology (215 citations), Hematology (126 citations), Toxicology (29 citations), Immunology (127 citations) and Psychiatry and Mental health (63 citations). Rachel E. Sobel has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Michael D. Lockshin, Jane E. Salmon, Alfred Zettner, C. A. Finch, Doruk Erkan, Yusuf Yazıcı, Larry Gorkin, Richard L. Siegel, Kyle Hvidsten and Arthur M.F. Yee. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, International Journal of Clinical Practice, International Journal of Medical Informatics, Clinical Pharmacology & Therapeutics and Ophthalmology Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.